Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Levasseur

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Environment International|December 20, 2020
Young children's exposure to phenols in the home: Associations between house dust, hand wipes, silicone wristbands, and urinary biomarkersJessica L Levasseur, Stephanie C Hammel, Kate Hoffman, et al.
JACC. Basic to Translational Science|August 1, 2018
Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart FailureNikole J Byrne, Nirmal Parajuli, Jody L Levasseur, et al.
ESC Heart Failure|October 7, 2021
Chronic exogenous ketone supplementation blunts the decline of cardiac function in the failing heartShingo Takahara, Shubham Soni, Kiran Phaterpekar, et al.
Viruses|December 23, 2022
Dynamics and Patterning of 5-Hydroxytryptamine 2 Subtype Receptors in JC Polyomavirus EntryKashif Mehmood, Michael P Wilczek, Jeanne K DuShane, et al.
European Journal of Preventive Cardiology|September 30, 2025
Ketone therapy prevents semaglutide-induced loss of cardiac massMya A Schmidt, Yasser Abuetabh, Masaaki Naganuma, et al.
Circulation. Heart Failure|June 5, 2020
Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart FailureNikole J Byrne, Shubham Soni, Shingo Takahara, et al.
Circulation. Heart Failure|January 21, 2020
Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart FailureNikole J Byrne, Nobutoshi Matsumura, Zaid H Maayah, et al.
JCI Insight|June 9, 2026
Semaglutide-induced loss of skeletal muscle mass is blunted by co-administration of ketone estersYasser Abuetabh, Mya A Schmidt, Masaaki Naganuma, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Environment International|December 20, 2020
Young children's exposure to phenols in the home: Associations between house dust, hand wipes, silicone wristbands, and urinary biomarkersJessica L Levasseur, Stephanie C Hammel, Kate Hoffman, et al.
JACC. Basic to Translational Science|August 1, 2018
Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart FailureNikole J Byrne, Nirmal Parajuli, Jody L Levasseur, et al.
ESC Heart Failure|October 7, 2021
Chronic exogenous ketone supplementation blunts the decline of cardiac function in the failing heartShingo Takahara, Shubham Soni, Kiran Phaterpekar, et al.
Viruses|December 23, 2022
Dynamics and Patterning of 5-Hydroxytryptamine 2 Subtype Receptors in JC Polyomavirus EntryKashif Mehmood, Michael P Wilczek, Jeanne K DuShane, et al.
European Journal of Preventive Cardiology|September 30, 2025
Ketone therapy prevents semaglutide-induced loss of cardiac massMya A Schmidt, Yasser Abuetabh, Masaaki Naganuma, et al.
Circulation. Heart Failure|June 5, 2020
Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart FailureNikole J Byrne, Shubham Soni, Shingo Takahara, et al.
Circulation. Heart Failure|January 21, 2020
Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart FailureNikole J Byrne, Nobutoshi Matsumura, Zaid H Maayah, et al.
JCI Insight|June 9, 2026
Semaglutide-induced loss of skeletal muscle mass is blunted by co-administration of ketone estersYasser Abuetabh, Mya A Schmidt, Masaaki Naganuma, et al.
Pageof 4